drugset / Trial / NCT02575261
CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of CAR-T cell immunotherapy in treating with EphA2 positive malignant glioma patients.
Timeline
- Start
- 2015-09
- Primary completion
- 2016-08-15
- Completion
- 2016-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CAR-T cell immunotherapy | Cell therapy | — | Other |